date:Feb 20, 2019
Jennewein Biotechnologie GmbH, a leader in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), Chinas leading dairy company, announced recently the signing of a Memorandum of Understanding on infant microbiome and human milk oligosaccharides, with the goal to develop an innovative infant formula and dairy products specifically tailored to the Chinese market.
After already having introduced human milk oligosaccharides in other